Lataa...
COVID-19 and the liver: an adverse outcome pathway perspective
Liver damage is observed in up to half of hospitalized COVID-19 patients and can result either from actions of SARS-CoV-2 as such or from pharmacological treatment. The present paper introduces an adverse outcome pathway construct that mechanistically describes the pathways induced by SARS-CoV-2 lea...
Tallennettuna:
| Julkaisussa: | Toxicology |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7986318/ https://ncbi.nlm.nih.gov/pubmed/33771662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tox.2021.152765 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|